Search results
We’re on the road with a new approach to clinical trials—one that expands access to cutting-edge medicines and treatments. Lilly is a medicine company turning science into healing to make life better for people around the world.
- Careers
Find your place at Lilly with Lilly Careers. For more than a...
- Investor Relations
The Investor Relations website contains information about...
- Webcasts & Presentations
Speaker: Patrik Jonsson, Executive Vice President, President...
- Contact
If you are having trouble paying for a prescription for your...
- HCP Medical Information
Lilly Medical Information is committed to offering robust...
- Who We Are
We’re a medicine company turning science into healing to...
- Newsroom
Lilly's latest press releases, stories, news resources and...
- Our Locations
Our Locations | Lilly Careers ... Our Locations
- Careers
Footnotes / references. [1] [2] [3] [4] [5] Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
We’re a medicine company turning science into healing to make life better for people around the world. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges.
Find the latest Eli Lilly and Company (LLY) stock quote, history, news and other vital information to help you with your stock trading and investing.
Learn about Eli Lilly and Company, a global pharmaceutical company that turns science into healing. See their latest updates, specialties, locations, employees and more on LinkedIn.
Jun 25, 2024 · Find out the latest news, events, and results of Eli Lilly and Company, a global pharmaceutical company. Learn about its clinical development pipeline, ESG report, and key financial ratios.
Jun 25, 2024 · INDIANAPOLIS , June 25, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced a collaboration with OpenAI that will allow Lilly to leverage OpenAI 's generative AI to invent novel antimicrobials to treat drug-resistant pathogens.